中文 | English
Return
Total: 919 , 1/92
Show Home Prev Next End page: GO
Author:(Wei-feng HE)

1.Interpretation and thoughts on the formulation and revision of the standards for exogenous harmful residues in traditional Chinese medicinal materials in the Chinese Pharmacopoeia 2025 Edition

WANG Ying ; SHEN Mingrui ; LIU Yuanxi ; ZUO Tiantian ; WANG Dandan ; HE Yi ; CHENG Xianlong ; JIN Hongyu ; LIU Yongli ; WEI Feng ; MA Shuangcheng

Drug Standards of China 2025;26(1):083-092

2.Effects of citicoline on Keap1/Nrf2/ARE signaling pathway in mice with cerebral hemorrhage

Wei LU ; Hong YOU ; Min ZHANG ; Bao-Feng HE ; Rui MA ; Ya-Ya GAO ; Xin-Yu MA

The Chinese Journal of Clinical Pharmacology 2024;40(8):1175-1179

3.Determination of rifapentine concentration in human serum by two-dimensional liquid chromatography

Tao KE ; Tian HE ; Pei-Ze ZHANG ; Wei LI ; Yang ZHOU ; Feng WANG ; Miao-Na LIU

The Chinese Journal of Clinical Pharmacology 2024;40(11):1638-1641

4.Effects of total flavonoids of Oxytropis falcata Bunge on CCl4-induced liver fibrosis in rats

Tian-Yan YANG ; Xin-Huan MA ; Zhi-Wei XU ; Rong-Kun LI ; Fang-Xiong MA ; Bao-Feng HE ; Liang CHEN ; Xiao-Qing CHEN ; Jun ZHANG

The Chinese Journal of Clinical Pharmacology 2024;40(14):2073-2077

5.Expert Consensus on Clinical Diseases Responding Specifically to Traditional Chinese Medicine: Threatened Abortion

Xinchun YANG ; Shuyu WANG ; Huilan DU ; Songping LUO ; Zhe JIN ; Rong LI ; Xiangyan RUAN ; Qin ZHANG ; Xiaoling FENG ; Shicai CHEN ; Fengjie HE ; Shaobin WEI ; Qun LU ; Yanqin WANG ; Yang LIU ; Qingwei MENG ; Zengping HAO ; Ying LI ; Mei MO ; Xiaoxiao ZHANG ; Ruihua ZHAO

Chinese Journal of Experimental Traditional Medical Formulae 2024;30(7):241-246

6.Identification and anti-inflammatory activity of chemical constituents and a pair of new monoterpenoid enantiomers from the fruits of Litsea cubeba

Mei-lin LU ; Wan-feng HUANG ; Yu-ming HE ; Bao-lin WANG ; Fu-hong YUAN ; Ting ZHANG ; Qi-ming PAN ; Xin-ya XU ; Jia HE ; Shan HAN ; Qin-qin WANG ; Shi-lin YANG ; Hong-wei GAO

Acta Pharmaceutica Sinica 2024;59(5):1348-1356

7.Progress of biomacromolecule drug nanodelivery systems in the treatment of rare diseases

Shu-jie WEI ; Han-xing HE ; Jin-tao HAO ; Qian-qian LV ; Ding-yang LIU ; Shao-kun YANG ; Hui-feng ZHANG ; Chao-xing HE ; Bai XIANG

Acta Pharmaceutica Sinica 2024;59(7):1952-1961

8.miR-4645-5p regulates malignant biological behavior of esophageal cancer cells by targeting MUC16

Zhen ZHOU ; Linna JIANG ; Peng HE ; Feng YIN ; Ping WEI ; Xin AN ; Xianghong LI

International Journal of Laboratory Medicine 2024;45(1):54-59

9.Exploration the Immune Regulatory Mechanism of Hedysari Radix Based on Network Pharmacology,Molecular Dynamics,and UPLC-MS/MS

Xudong LUO ; Xinrong LI ; Chengyi LI ; Peng QI ; Tingting LIANG ; Xiaoli FENG ; Xu LI ; Jungang HE ; Xiaocheng WEI ; Ruijuan ZHOU ; Xinming XIE

Traditional Chinese Drug Research & Clinical Pharmacology 2024;35(3):376-383

10.miR-135a-5p regulates autophagy of mouse embryonic palatal mesenchymal cells via targeting Kif3B

Wenxuan FENG ; Shubo LIAN ; Zhe WANG ; Jing CHEN ; Wei HE

Chinese Journal of Tissue Engineering Research 2024;28(19):3003-3011

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 919 , 1/92 Show Home Prev Next End page: GO